(RTTNews) - GE HealthCare Technologies Inc. (GEHC) Monday announced results from the Phase 1 study of its manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. The data showed ...
Some results have been hidden because they may be inaccessible to you